(i) ERBB/HER family members and their cognate ligands (ii) Structural difference of various (I-VI) types of NRG1

A (i) ERBB/HER family members and their cognate ligands (ii) Structural difference of various (I-VI) types of NRG1. Abbreviations: CD, cytoplastmic domain; CRD, Cysteine-rich domain; ECD, extracellular domain; EGF, epidermal growth factor; EGF-L; EGF-like repeat; HB-EGF, heparin-binding EGF-like growth factor; Ig, Ig-like C2-type domain; LIMK, LIM kinase; N-CoR, Nuclear receptor co-repressor; TA B2, TGF-Beta Activated Kinase 1 (MAP3K7) Binding Protein 2); TGF, transforming growth factor; TM, transmembrane; TMD, transmembrane domain; WT, wild type. B Examples of various fusions of NRG1. The structure of some representative variants of NRG1 fusions is shown. The EGF domain is preserved in all fusion proteins. C ERBB/HER family and potential downstream cascades. Figure represents possible sets for ERBB3/HER3 or ERBB4/HER4 dimerization with other ERBB/HER family members (HER1:HER4, HER1:HER3, HER2:HER4, HER4:HER4, HER3:HER4, and HER2:HER3) and their ligand(s) (e.g., NRG1, 2, 3, and 4) binding or their binding with EGF-like structure of NRG1 fusion-protein. Note that ERBB4/HER4 is also known as ALS19. NRG1 fusion-protein exerts a tumorigenic effect that requires HER2:HER3 heterodimerization-mediated activation, which can result in oncogenic signaling. The NRG1 fusion product is a transmembrane protein with an extracellular EGF-like domain that binds to ERBB3/HER3 in the cell membrane (see inside the box). NRG or NRG1-fusion-induced HER2:HER3 heterodimerization is depicted as the inset. The binding of ligands to receptors triggers dimerization and activation of the downstream signaling events responsible for tumorigenesis. Out of four family members, ERBB3/HER3 has six YXXM motifs responsible for the recruitment of p85, leading to activation of the PI3K-AKT-mTOR pathway. Other receptor dimerization also activates the RAS-RAF-MAPK pathway responsible for proliferation and survival. The NRG-HER signaling pathway also activates downstream JAK-STAT and PLCγ-PKC pathways, and both play a role in various oncogenic phenotypes. Examples of FDA-approved drugs are shown in the red color font, and examples of non-approved drugs are presented in blue font (inside the box). ERBB2/HER2 may also interact with ERBB3/HER3 and IGF1R to form heterotrimeric complex (HER2-HER3-IGF1R) [not shown in the figure] in trastuzumab-resistant breast cancer cells. D NRG1-mediated ERBB4/HER4 activation forward signaling (non-canonical). Non-canonical ERBB4/HER4 (also known as ALS19) forward signaling is shown. The ERBB4/HER4 intracellular domain is cleaved by γ-secretase (or others) (separated from the extracellular domain (ECD); the ERBB4/HER4 intracellular domain translocates to the nucleus to regulate gene expression. Also, NRG1-mediated HER4 activation (phosphorylation) promotes the association with an adaptor protein TA B2. TA B2 also recruits N-CoR and forms a signaling complex that, upon translocation to the nucleus, represses the transcription of certain genes required for the differentiation of neuronal precursor cells. E NRG1- mediated backward signaling. For NRG1-mediated backward signaling, the C-terminal fragment of NRG1 (CD: cytoplasmic domain) is cleaved from the Pro-NRG1 by the help of a protease; NRG1 CD may translocate to the nucleus to regulate gene transcription. The CD of Pro-NRG1 also interacts with LIM kinase (LIMK). LIMK (a non-receptor tyrosine kinase) has been shown to regulate cytoskeletal rearrangement/actin dynamics in many cell types including neuronal cells. In addition, ERBB4/HER4 (ALS19) or its diffusible extracellular domain can act as a ligand for pro-NRG1
(i) ERBB/HER family members and their cognate ligands (ii) Structural difference of various (I-VI) types of NRG1

Publication

Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer (2024) Jacob J. Adashek, et al. BMC Med. 2024;22(NA). Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates NRG1 NRG1 ncbigene_symbol NRG1 3084
Homo sapiens Primates A(ii) AII ncbigene_synonym NLRP3 114548
Homo sapiens Primates ERBB ERBB ncbigene_synonym EGFR 1956
Homo sapiens Primates ERBB ERBB famplex_relations ERBB2 2064
Homo sapiens Primates ERBB ERBB famplex_relations ERBB3 2065
Homo sapiens Primates ERBB ERBB famplex_relations ERBB4 2066
Homo sapiens Primates HB-EGF HBEGF ncbigene_symbol HBEGF 1839
Homo sapiens Primates N-CoR N-COR ncbigene_synonym NCOR1 9611
Homo sapiens Primates TAB2 TAB2 ncbigene_symbol TAB2 23118
Homo sapiens Primates NRG2 NRG2 ncbigene_symbol NRG2 9542
Homo sapiens Primates NRG3 NRG3 ncbigene_symbol NRG3 10718
Homo sapiens Primates NRG4 NRG4 ncbigene_symbol NRG4 145957
Homo sapiens Primates EGF. EGF ncbigene_symbol EGF 1950
Homo sapiens Primates mTORC2) MTORC2 famplex_relations MAPKAP1 79109
Homo sapiens Primates mTORC2) MTORC2 famplex_relations MTOR 2475
Homo sapiens Primates mTORC2) MTORC2 famplex_relations RICTOR 253260
Homo sapiens Primates mTORC2) MTORC2 famplex_relations MLST8 64223
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CA 5290
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CB 5291
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CD 5293
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CG 5294
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R3 8503
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R4 30849
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R5 23533
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R6 146850
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R1 5295
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R2 5296
Homo sapiens Primates RAS RAS famplex_relations KRAS 3845
Homo sapiens Primates RAS RAS famplex_relations HRAS 3265
Homo sapiens Primates RAS RAS famplex_relations NRAS 4893
Homo sapiens Primates CRAF CRAF ncbigene_synonym RAF1 5894
Homo sapiens Primates AKT AKT ncbigene_synonym AKT1 207
Homo sapiens Primates AKT AKT famplex_relations AKT2 208
Homo sapiens Primates AKT AKT famplex_relations AKT3 10000
Homo sapiens Primates RAF RAF ncbigene_synonym ZHX2 22882
Homo sapiens Primates RAF RAF famplex_relations ARAF 369
Homo sapiens Primates RAF RAF famplex_relations BRAF 673
Homo sapiens Primates (MEK MEK ncbigene_synonym MAP2K7 5609
Homo sapiens Primates (MEK MEK famplex_relations MAP2K1 5604
Homo sapiens Primates (MEK MEK famplex_relations MAP2K2 5605
Homo sapiens Primates SAC SAC ncbigene_synonym ADCY10 55811
Homo sapiens Primates TOR TOR ncbigene_synonym RORC 6097
Homo sapiens Primates TBC1 TBC1 ncbigene_synonym TBC1D1 23216
Homo sapiens Primates TSC2 TSC2 ncbigene_symbol TSC2 7249
Homo sapiens Primates ERK ERK ncbigene_synonym EPHB2 2048
Homo sapiens Primates ERK ERK ncbigene_synonym MAPK1 5594
Homo sapiens Primates ERK ERK famplex_relations MAPK3 5595
Homo sapiens Primates (MEX) MEX ncbigene_synonym ZSWIM2 151112
Homo sapiens Primates BAT BAT ncbigene_synonym BAAT 570
Homo sapiens Primates Rheb RHEB ncbigene_symbol RHEB 6009
Homo sapiens Primates Rheb RHEB ncbigene_synonym RHEBP1 6008
Homo sapiens Primates PKC PKC ncbigene_synonym PRRT2 112476
Homo sapiens Primates PKC PKC famplex_relations PRKCA 5578
Homo sapiens Primates PKC PKC famplex_relations PRKCB 5579
Homo sapiens Primates PKC PKC famplex_relations PRKCD 5580
Homo sapiens Primates PKC PKC famplex_relations PRKCE 5581
Homo sapiens Primates PKC PKC famplex_relations PRKCG 5582
Homo sapiens Primates PKC PKC famplex_relations PRKCH 5583
Homo sapiens Primates PKC PKC famplex_relations PRKCI 5584
Homo sapiens Primates PKC PKC famplex_relations PRKCQ 5588
Homo sapiens Primates PKC PKC famplex_relations PRKCZ 5590
Homo sapiens Primates PKC PKC famplex_relations PRKD3 23683
Homo sapiens Primates 4EBP1 4EBP1 ncbigene_synonym EIF4EBP1 1978
Homo sapiens Primates Trip TRIP ncbigene_synonym LRRFIP1 9208
Homo sapiens Primates Trip TRIP ncbigene_synonym TRAIP 10293
Homo sapiens Primates Trip TRIP ncbigene_synonym PIK3IP1 113791
Homo sapiens Primates UMK UMK ncbigene_synonym CMPK1 51727

Chemical mentions

Word Match MeSH Name ChEBI
NRG1 NRG1 chebi:231555
TAD TAD 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione - ethane-1,2-diamine (2:1) chebi:2659
NRG1 NRG1 chebi:231555
NRG1 NRG1 chebi:231555
EGF EGF L-alpha-glutamylglycyl-L-phenylalanine chebi:140739
NRG1 NRG1 chebi:231555
Afatinib afatinib (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide chebi:61390
RAS RAS (1R)-N-(prop-2-yn-1-yl)indan-1-amine chebi:63620
Pla PLA chebi:60159
RAS RAS (1R)-N-(prop-2-yn-1-yl)indan-1-amine chebi:63620
MEK MEK butan-2-one chebi:28398
DAB DAB biphenyl-3,3',4,4'-tetramine chebi:90994
MEK MEK butan-2-one chebi:28398
Afatinib afatinib (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide chebi:61390
Afatinib afatinib (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide chebi:61390
Neratinib neratinib (2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide chebi:61397
EGF EGF L-alpha-glutamylglycyl-L-phenylalanine chebi:140739
EGF EGF L-alpha-glutamylglycyl-L-phenylalanine chebi:140739
EGF EGF L-alpha-glutamylglycyl-L-phenylalanine chebi:140739
EGF EGF L-alpha-glutamylglycyl-L-phenylalanine chebi:140739

Disease mentions

Word Match MeSH Name DOID